Marc Pelletier

Marc Pelletier

Company: Novartis

Job title: Senior Principal Scientist


Fireside chat: Utilizing RNA-Seq for Better Pre-Clinical Predictions & Patient Identification 11:15 am

Screening for actionable targets based on targeted RNA-sequencing to make a more accurate prediction of drug efficacy How to preserve the complexity of tumor biology in models? Can we use RNAseq to understand MoA? Can we use baseline RNAseq readouts as patients selection? Is this practical with a gene signature, or do we need to…Read more

day: Preclinical Track - Day 1 am

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.